Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis ; volume:25 ; number:1 ; day:12 ; month:9 ; year:2023 ; pages:1-12 ; date:12.2023
Arthritis Research & Therapy ; 25, Heft 1 (12.9.2023), 1-12, 12.2023
- Urheber
-
Cauvet, Anne
Decellas, Arthur
Guignabert, Christophe
Rongvaux-Gaïda, Dominique
Thuillet, Raphaël
Ottaviani, Mina
Tu, Ly
Rieger, François
Avouac, Jérôme
Allanore, Yannick
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-023-03143-2
- URN
-
urn:nbn:de:101:1-2024020612524366714472
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cauvet, Anne
- Decellas, Arthur
- Guignabert, Christophe
- Rongvaux-Gaïda, Dominique
- Thuillet, Raphaël
- Ottaviani, Mina
- Tu, Ly
- Rieger, François
- Avouac, Jérôme
- Allanore, Yannick
- SpringerLink (Online service)
Ähnliche Objekte (12)
PML-RARA mutations confer varying arsenic trioxide resistance
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
PML and its degradation by arsenic trioxide in interferon-mediated neuro-inflammation
PML-RARA mutations confer varying arsenic trioxide resistance
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
PML and its degradation by arsenic trioxide in interferon-mediated neuro-inflammation
PML-RARA mutations confer varying arsenic trioxide resistance
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9